SCHEMBL11985604

SCHEMBL11985604

CNN1C(=O)CSC1=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28604051 0.74 MAPT (0.50)
SCHEMBL302289 0.71 MAPT (0.51)
3-Methyl-Rhodanine SCHEMBL181527 0.70
SCHEMBL6324088 0.69 MAPT (0.67)
SCHEMBL10784807 0.67 MAPT (0.47)
SCHEMBL8224178 0.67 MAPT (0.58)
SCHEMBL3075872 0.67 KMT2A (0.67)
SCHEMBL7715258 0.65
SCHEMBL8956616 0.65
SCHEMBL1275424 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120295856-A1 FREDERICAMYCIN DERIVATIVES ZENTOPHARM GMBH (DE) 2012-11-22 US disclosed
US-8247424-B2 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers ZENTOPHARM GMBH (DE) 2012-08-21 US disclosed
US-8247424-B2 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers ZENTOPHARM GMBH (DE) 2012-08-21 US disclosed
EP-2172457-A2 Fredericamycin derivatives Biofrontera Discovery Gmbh (DE) 2010-04-07 EP disclosed
EP-1503988-B1 FREDERICAMYCIN DERIVATIVES BIOFRONTERA DISCOVERY GMBH (DE) 2009-07-22 EP disclosed
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2008-01-03 US disclosed